NCT00036140View on ClinicalTrials.gov

Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Multiple Myeloma
Interventions
DRUG

Investigational drug

Trial Locations (5)

44106

Research Center, Cleveland

54449

Research Center, Marshfield

90033

Research Center, Los Angeles

90048

Research Center, Los Angeles

92270

Research Center, Rancho Mirage

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00036140 - Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter